Skip main navigation
Close Drawer MenuOpen Drawer Menu

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
CorrectionsFull Access

CORRECTIONS

Published Online:1 Jun 2017https://doi.org/10.1176/appi.ajp.2017.1746correction2

In the editorial “Hallucinations Predict Relapse After Discontinuation of Risperidone in Patients With Alzheimer’s Disease and Psychosis or Agitation” by Helen Lavretsky, M.D., M.S. (http://dx.doi.org/10.1176/appi.ajp.2016.16111314), published in the April 2017 issue of the Journal, the first sentence of the last paragraph should have specified auditory, not visual, hallucinations as indicating a high risk of relapse. The online edition was corrected on May 2, 2017.